Skip to main content

Want a detailed portfolio tracker?

Inventiva (IVA) P/E (2020 - 2026)

Inventiva (IVA) P/E from Jul 10, 2020 to Jul 21, 2026. The TTM Inventiva (IVA) P/E is -0.66. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Inventiva (IVA)

YearP/EChange
2026-0.66-3.66%
2025-0.69+45.25%
2024-0.47-62.58%
2023-1.26-36.38%
2022-1.98-70.01%
2021-6.61-28.97%
2020-9.31N/A

Comparison Inventiva (IVA) P/E with competitors

Inventiva (IVA) P/E is -0.66.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.26%
NBYStablecoin Development Corp0.00-100.65%
ENLVEnlivex Ltd0.07-111.32%
FGENFibroGen Inc0.24-136.33%
CHRSCoherus Biosciences Inc0.85-228.43%
FBIOFortress Biotech Inc0.95-243.64%
ORMPOramed Pharmaceuticals Inc1.50-327.50%
AGENAgenus Inc3.01-555.52%
INVAInnoviva Inc3.15-577.38%
VXRTVaxart Inc3.55-637.27%
CRMDCorMedix Inc3.63-649.19%
CVACCureVac N.V.4.45-772.88%
GLPGGalapagos NV4.86-835.42%
SRPTSarepta Therapeutics Inc4.88-838.93%
ABEOAbeona Therapeutics Inc5.39-915.43%
ABUSArbutus Biopharma Corp5.60-946.93%
ZVRAZevra Therapeutics Inc5.89-991.07%
SPROSpero Therapeutics Inc6.23-1042.71%
CGENCompugen Ltd6.31-1055.65%
RIGLRigel Pharmaceuticals6.87-1140.13%
SLXNSilexion Therapeutics Corp7.30-1204.31%
OMEROmeros Corporation9.26-1501.37%
AUPHAurinia Pharmaceuticals Inc9.58-1550.74%
PLXProtalix BioTherapeutics Inc10.89-1748.42%
ACADAcadia Pharmaceuticals Inc11.73-1875.19%
TBPHTheravance Biopharma Inc12.26-1955.95%
ADMAAdma Biologics Inc12.42-1979.57%
HRMYHarmony Biosciences Holdings Inc13.82-2191.78%
SABSSAB Biotherapeutics Inc14.14-2239.61%
NAGENiagen Bioscience Inc14.82-2342.82%
INCYIncyte Corp15.82-2494.85%
REGNRegeneron Pharmaceuticals Inc15.86-2500.01%
PBYIPuma Biotechnology Inc17.32-2720.85%
CPRXCatalyst Pharmaceuticals Inc17.44-2739.55%
EXELExelixis Inc17.54-2754.49%
TGTXTG Therapeutics Inc18.97-2970.64%
MDXGMimedx Group Inc20.55-3210.76%
XOMAXOMA Royalty Corp22.87-3562.33%
ARGXArgen X SE24.30-3777.76%
CTMXCytomX Therapeutics Inc24.82-3856.94%
XOMAOXOMA Royalty Corp25.34-3936.21%
HALOHalozyme Therapeutics Inc25.62-3978.42%
XOMAPXOMA Royalty Corp25.67-3985.44%
VRTXVertex Pharmaceuticals Inc27.99-4337.30%
RPRXRoyalty Pharma plc - Class A28.69-4442.16%
SLNOSoleno Therapeutics Inc29.02-4491.78%
ASNDAscendis Pharma A/S30.09-4653.77%
LGNDLigand Pharmaceuticals Inc - Class B37.91-5838.39%
APLSApellis Pharmaceuticals Inc39.02-6006.28%
BMRNBiomarin Pharmaceutical Inc42.21-6489.21%
KRYSKrystal Biotech Inc45.34-6963.22%
ONCBeiGene Ltd69.54-10625.69%
PHARPharming Group N.V.75.03-11455.92%
TECHBio-Techne Corp101.96-15532.49%
VCELVericel Corp109.92-16737.77%
ALNYAlnylam Pharmaceuticals Inc117.96-17955.28%
GMABGenmab140.29-21334.51%
TLXTelix Pharmaceuticals Ltd162.15-24643.57%
CORTCorcept Therapeutics Inc212.86-32318.27%